Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000673729 | SCV000798965 | likely pathogenic | Niemann-Pick disease, type C2 | 2018-04-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000673729 | SCV004437534 | pathogenic | Niemann-Pick disease, type C2 | 2023-10-25 | criteria provided, single submitter | clinical testing | This sequence change affects the initiator methionine of the NPC2 mRNA. The next in-frame methionine is located at codon 79. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individual(s) with Niemann-Pick disease type C (PMID: 19252935, 24915861). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 557572). This variant disrupts a region of the NPC2 protein in which other variant(s) (p.Cys47Phe) have been observed in individuals with NPC2-related conditions (PMID: 12955717, 15937921, 17470133). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |